The different ways our immune systems respond to infections could mean the difference in life and death for those fighting COVID-19.

Researchers have identified two forms of immune-boosting T cells that fight infections. T cells are known as the immune warriors that help us fight viruses and other germs. One type of T cell is called the "helper" cell, while the second is the "killer" that destroys virus cells with toxic chemicals. Experts say COVID-19 patients who come seriously ill with the disease, may be missing the teamwork between these two types of cells.

According to the South China Morning Post, researchers from the University of Pennsylvania discovered that there are three types of immunity variations that can affect how your body responds to disease.

In the first type, there are too many helper cells to direct the attack and hot enough warriors or killer cells to complete the task. The second type involves too may killer cells ready to attack that lack a coordinated plan from the helper cells. Lastly, the researchers found some people do not make enough of either type and are the most at risk of dying.

The scientists said the patent's overall health might determine the balance of T cells and while most COVID-19 patients receive the same treatment, the new evidence suggests more individualized protocols should be examined. 

"The findings promote the idea of tailoring clinical treatments or future immune-based clinical trials for patients whose immunotype suggests a greater potential benefit," they said.

Dr. David Brownstein, of the nation's foremost practitioners of holistic medicine and the editor of Dr. Brownstein's Natural Way to Health newsletter tells Newsmax:

"There is a cure for every viral infection known to mankind and that is the immune system. When the immune system appropriately responds to a foreign pathogen, it can do wonderful things. Supporting the immune system should be our top priority in fighting viruses including the coronavirus."